Page last updated: 2024-08-23

fluorescamine and Ovarian Neoplasms

fluorescamine has been researched along with Ovarian Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Babu, A; Munshi, A; Muralidharan, R; Ramesh, R; Shanker, M; Wang, Q	1

Other Studies

1 other study(ies) available for fluorescamine and Ovarian Neoplasms

Article	Year
Chitosan coated polylactic acid nanoparticle-mediated combinatorial delivery of cisplatin and siRNA/Plasmid DNA chemosensitizes cisplatin-resistant human ovarian cancer cells. Molecular pharmaceutics, 2014, Aug-04, Volume: 11, Issue:8 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Cisplatin; Drug Delivery Systems; Drug Resistance, Neoplasm; Female; Fluorescamine; Humans; Inhibitory Concentration 50; Lactic Acid; Nanomedicine; Nanoparticles; Ovarian Neoplasms; Particle Size; Plasmids; Polyesters; Polymers; Proteasome Endopeptidase Complex; RNA-Binding Proteins; RNA, Small Interfering	2014

Article

Year

Chitosan coated polylactic acid nanoparticle-mediated combinatorial delivery of cisplatin and siRNA/Plasmid DNA chemosensitizes cisplatin-resistant human ovarian cancer cells.

Molecular pharmaceutics, 2014, Aug-04, Volume: 11, Issue:8

Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Cisplatin; Drug Delivery Systems; Drug Resistance, Neoplasm; Female; Fluorescamine; Humans; Inhibitory Concentration 50; Lactic Acid; Nanomedicine; Nanoparticles; Ovarian Neoplasms; Particle Size; Plasmids; Polyesters; Polymers; Proteasome Endopeptidase Complex; RNA-Binding Proteins; RNA, Small Interfering

2014